The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: Rationale and sample characteristics

References

• Addington J., Burnett P. Working with families in the early stages of psychosis. Psychological interventions in early psychosis: A treatment handbook, J. F. Gleeson, P. D. McGorry. Wiley, Chichester 2004; 99–116
   Google Scholar
• Addington J., McCleery A., Addington D. Three-year outcome of family work in an early psychosis program. Schizophrenia Research 2005; 79: 107–116
   PubMed Web of Science ®Google Scholar
• Almond S., Knapp M., Francois C., Toumi M., Brugha T. Relapse in schizophrenia: Costs, clinical outcomes and quality of life. British Journal of Psychiatry 2004; 184: 346–351
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. American Psychiatric Association, Washington, DC 1994
   Google Scholar
• Andreasen N. C. Scale for Assessment of Negative Symptoms (SANS). University of Iowa, Iowa City 1984
   Google Scholar
• Andreasen N. C., Carpenter W. T., Jr., Kane J. M., Lasser R. A., Marder S. R., Weinberger D. R. Remission in schizophrenia: Proposed criteria and rationale for consensus. American Journal of Psychiatry 2005; 162: 441–449
   PubMed Web of Science ®Google Scholar
• Birchwood M., Smith J., Macmillan F., Hogg B., Prasad R., Harvey C., Bering S. Predicting relapse in schizophrenia: The development of an early signs monitoring system using patients and families as observers, a preliminary investigation. Psychological Medicine 1989; 19: 649–656
   PubMed Web of Science ®Google Scholar
• Bola J. R., Mosher L. R. At issue: Predicting drug-free treatment response in acute psychosis from the Soteria project. Schizophrenia Bulletin 2002; 28: 559–575
   PubMed Web of Science ®Google Scholar
• Buchanan R. W., Carpenter W. T. Targeted maintenance treatment in schizophrenia - Issues and recommendations. CNS Drugs 1996; 5: 240–245
   Google Scholar
• Carpenter W. T., Jr., Appelbaum P. S., Levine R. J. The Declaration of Helsinki and clinical trials: A focus on placebo-controlled trials in schizophrenia. American Journal of Psychiatry 2003; 160: 356–362
   PubMed Web of Science ®Google Scholar
• Crow T. J., Macmillan J. F., Johnstone A. L., Johnstone E. C. The Northwick Park study of first episodes of schizophrenia II. A randomized controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry 1986; 148: 120–127
   PubMed Web of Science ®Google Scholar
• Early Psychosis Prevention and Intervention Centre. Case management in early psychosis: A handbook. Parkville, VictoriaAustralia 2001
   Google Scholar
• Edwards J., Harris M., Herman A. The early psychosis prevention and intervention centre, Melbourne, Australia: An overview, November 2001. Recent advances in early intervention and prevention in psychiatric disorders, C. Ogura. Seiwa Shoten, Tokyo 2002; 26–33
   Google Scholar
• Edwards J., Elkins K., Hinton M., Harrigan S. M., Donovan K., Athanasopoulos O., McGorry P. D. Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatrica Scandinavica 2006; 114: 109–117
   PubMed Web of Science ®Google Scholar
• Edwards J., McGorry P. D. Implementing early intervention in psychosis: A guide to establishing early psychosis services. Martin Dunitz, London 2002
   Google Scholar
• Falloon I. R. Handbook of behavioral family therapy. Guilford Press, New York 1988
   Google Scholar
• Fenton W. S., Mosher L. R., Herrell J. M., Blyler C. R. Randomized trial of general hospital and residential alternative care for patients with severe and persistent mental illness. American Journal of Psychiatry 1998; 155: 516–522
   PubMed Web of Science ®Google Scholar
• First M. B., Spitzer R. L., Williams J. B. W., Gibbon M. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) user's guide and interview. American Psychiatric Press, Washington, DC 1997
   Google Scholar
• Fitzgerald P. B., Williams C. L., Corteling N., Filia S. L., Brewer K., Adams A., de Castella A. R. A., Rolfe T., Davey P., Kulkarni J. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatrica Scandinavica 2001; 103: 387–392
   PubMed Web of Science ®Google Scholar
• Gilbert M., Miller K., Berk L., Ho V., Castle D. Scope for psychosocial treatments in psychosis: An overview of collaborative therapy. Australasian Psychiatry 2003; 11: 220–224
   Google Scholar
• Gilbert P. L., Harris M. J., McAdams L., Jeste D. V. Neuroleptic withdrawal in schizophrenic patients: A review of the literature. Archives of General Psychiatry 1995; 52: 173–188
   PubMed Web of Science ®Google Scholar
• Gitlin M., Nuechterlein K., Subotnik K. L., Ventura J., Mintz J., Fogelson D. L., Bartzokis G., Aravagiri M. Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. American Journal of Psychiatry 2001; 158: 1835–1842
   PubMed Web of Science ®Google Scholar
• Gleeson J. F. The first psychotic relapse: Understanding the risks and the opportunities for prevention. Psychological interventions in early psychosis: A treatment handbook, J. F. Gleeson, P. D. McGorry. Wiley, Chichester 2004; 157–174
   Google Scholar
• Goldberg D. P. The detection of psychiatric illness by questionnaire: A technique for the identification and assessment of non-psychotic psychiatric illness. Oxford University Press, London 1972, Maudsley Monograph
   Google Scholar
• Goldman H. H., Skodol A. E., Lave T. R. Revising Axis-V for DSM-IV – a review of measures of social functioning. American Journal of Psychiatry 1992; 149: 1148–1156
   PubMed Web of Science ®Google Scholar
• Gumley A., O'Grady M., McNay L., Reilly J., Power K., Norrie J. Early intervention for relapse in schizophrenia: Results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine 2003; 33: 419–431
   PubMed Web of Science ®Google Scholar
• Gupta R. K., Chavan B. S., Kulhara P. Psychosis NOS: A retrospective study. Indian Journal of Psychological Medicine 1988; 11: 113–118
   Google Scholar
• Hilsenroth M. J., Ackerman S. J., Blagys M. D., Baumann B. D., Baity M. R., Smith S. R., Price J. L., Smith C. L., Heindselman T. L., Mount M. K., Holdwick D. J. Reliability and validity of DSM-IV axis V. American Journal of Psychiatry 2000; 157: 1858–1863
   PubMed Web of Science ®Google Scholar
• Hogarty G. E. Personal therapy for schizophrenia and related disorders: A guide to individualized treatment. Guilford Press, New York 2002
   Google Scholar
• Jackson H., McGorry P., Edwards J., Hulbert C., Henry L., Francey S., Maude D., Cocks J., Power P., Harrigan S., Dudgeon P. Cognitively-oriented psychotherapy for early psychosis (COPE): Preliminary results. British Journal of Psychiatry 1998; 172(Suppl. 33)93–100
   Google Scholar
• Jackson H., McGorry P., Henry L., Edwards J., Hulbert C., Harrigan S., et al. Cognitively oriented psychotherapy for early psychosis (COPE): A 1-year follow-up. British Journal of Clinical Psychology 2001; 40: 57–70
   PubMed Web of Science ®Google Scholar
• Kane J. M., Rifkin A., Quitkin F., Nayak D., Ramos-Lorenzi J. Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia. Archives of General Psychiatry 1982; 39: 70–73
   PubMed Web of Science ®Google Scholar
• Lehman A. F., Kreyenbuhl J., Buchanan R. W., Dickerson F. B., Dixon L. B., Goldberg R., Green-Paden L. D., Tenhula W. N., Boerescu D., Tek C., Sandson N., Steinwachs D. M. The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003. Schizophrenia Bulletin 2004; 30: 193–217
   PubMed Web of Science ®Google Scholar
• Lehtinen V., Aaltonen J., Koffert T., Räkköläinen V., Syvälahti E. Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed?. European Psychiatry 2000; 15: 312–320
   PubMed Web of Science ®Google Scholar
• Leucht S., Barnes T. R. E., Kissling W., Engel R. R., Correll C., Kane J. M. Relapse prevention in schizophrenia with new-generation antipsychotics: A systematic review and exploratory meta-analysis of randomized, controlled trials. American Journal of Psychiatry 2003; 160: 1209–1222
   PubMed Web of Science ®Google Scholar
• Lieberman J. A., Jody D., Geisler S. Time course and biological correlates of treatment response in first-episode schizophrenia. Journal of Clinical Psychiatry 1993; 57: 5–9
   Google Scholar
• Lieberman J. A., Stroup T. S., McEvoy J. P., Swartz M. S., Rosenheck R. A., Perkins D. O., Keefe R. S. E., Davis S. M., Davis C. E., Lebowitz B. D., Severe J., Hsiao J. K. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 2005; 353: 1209–1223
   PubMed Web of Science ®Google Scholar
• Linszen D. H., Dingemans P., Van Der Does J. W., Nugter A., Scholte P., Lenior R., Goldstein M. J. Treatment, expressed emotion and relapse in recent onset schizophrenic disorders. Psychological Medicine 1996; 26: 333–342
   PubMed Web of Science ®Google Scholar
• Linszen D. H., Wouters L., Dingemans P., de Haan L., Nieman D. Early and 3-year sustained intervention in first episode schizophrenia: Relapse, stabilization and its predictors [Abstract]. Schizophrenia Research 2004; 67(Suppl. 1)18
   Google Scholar
• Lukoff D., Liberman R. P., Nuechterlein K. H. Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophrenia Bulletin 1986; 12: 578–593
   PubMed Web of Science ®Google Scholar
• Marwaha S., Johnson S. Schizophrenia and employment: A review. Social Psychiatry and Psychiatric Epidemiology 2004; 39: 337–349
   PubMed Web of Science ®Google Scholar
• McFarlane W. R., Dixon L., Lukens E., Lucksted A. Family psychoeducation and schizophrenia: A review of the literature. Journal of Marital & Family Therapy 2003; 29: 223–245
   PubMed Web of Science ®Google Scholar
• McGorry P. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry 2005; 39: 1–30
   PubMed Web of Science ®Google Scholar
• McGorry P. D., Edwards J., Mihalopoulos C., Harrigan S. M., Jackson H. J. EPPIC: An evolving system of early detection and optimal management. Schizophrenia Bulletin 1996; 22: 305–326
   PubMed Web of Science ®Google Scholar
• Montgomery S. M. Depressive symptoms in acute schizophrenia. Progress in Neuro-Psychopharmacology 1979; 3: 429–433
   PubMedGoogle Scholar
• Mueser K. T., Glynn S. M. Behavioral family therapy for psychiatric disorders, 2nd ed. New Harbinger, Oakland, CA 1999
   Google Scholar
• Müller N. Mechanisms of rrelapse prevention in schizophrenia. Pharmacopsychiatry 2004; 37(Suppl. l2)S141–S147
   PubMedGoogle Scholar
• National Early Psychosis Project Clinical Guidelines Working Party. Australian clinical guidelines for early psychosis. National Early Psychosis Project, University of Melbourne, Melbourne 1998
   Google Scholar
• Nuechterlein K. H., Dawson M. E., Gitlin M., Ventura J., Goldstein M. J., Snyder K. S., Yee C. M., Mintz J. Developmental processes in schizophrenic disorders: Longitudinal studies of vulnerability and stress. Schizophrenia Bulletin 1992; 18: 387–424
   PubMed Web of Science ®Google Scholar
• Overall J. E., Gorham D. R. The Brief Psychiatric Rating Scale. Psychiatric Reports 1962; 10: 799–812
   Web of Science ®Google Scholar
• Perepletchikova F., Kazdin A. E. Treatment integrity and therapeutic change: Issues and research recommendations. Clinical Psychology: Science and Practice 2005; 12: 365–383
   Web of Science ®Google Scholar
• Pourmand D., Kavanagh D. J., Vaughan K. Expressed emotion as predictor of relapse in patients with comorbid psychoses and substance use disorder. Australian and New Zealand Journal of Psychiatry 2005; 39: 473–478
   PubMed Web of Science ®Google Scholar
• Pilling S., Bebbington P., Kuipers E., Garety P., Geddes J., Orbach G., Morgan C. Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine 2002; 32: 763–782
   PubMed Web of Science ®Google Scholar
• Power P., Iacoponi E., Russell M., Fisher H., McGuire P., Garety P., Valmaggio L., Craig T. A randomised controlled trial of an early detection team in first-episode psychosis: Provisional findings of the LEO CAT study. Schizophrenia Research 2004; 70: 131–131
   Google Scholar
• Robinson D. G., Woerner M. G., Alvir J. M. J., Bilder R., Goldman R., Geisler S., Koreen A., Sheitman B., Chakos M., Mayerhoff D., Lieberman J. A. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 1999; 56: 241–247
   PubMed Web of Science ®Google Scholar
• Ryle A., Kerr I. B. Introducing cognitive analytic therapy: Principles and practice. Wiley, Chichester 2002
   Google Scholar
• Schooler N., Rabinowitz J., Davidson M., Emsley R., Harvey P. D., Kopala L., McGorry P. D., Van Hove I., Eerdekens M., Swyzen W., De Smedt G. Risperidone and haloperidol in first-episode psychosis: A long-term randomized trial. American Journal of Psychiatry 2005; 162: 947–953
   PubMed Web of Science ®Google Scholar
• Szmukler G. I., Burgess P., Herrman H., Benson A. Caring for relatives with serious mental illness: The development of Experience of Caregiving Inventory. Social Psychiatry & Psychiatric Epidemiology 1996; 31: 137–148
   PubMed Web of Science ®Google Scholar
• Ventura J., Liberman R. P., Green M. F., Shaner A., Mintz J. Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Research 1998; 79: 163–173
   PubMed Web of Science ®Google Scholar
• Wade D., Harrigan S., Edwards J., Burgess P. M., Whelan G., McGorry P. D. Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis. Australian and New Zealand Journal of Psychiatry 2005; 39: 892–898
   PubMed Web of Science ®Google Scholar
• Wiedemann G., Rayki O., Feinstein E., Hahlweg K. The Family Questionnaire: Development and validation of a new self-report scale for assessing expressed emotion. Psychiatry Research 2002; 109: 265–280
   PubMed Web of Science ®Google Scholar
• Wiersma D., Nienhuis F. J., Sloof C. J., Giel R. Natural course of schizophrenic disorders: A 15-year follow-up of a Dutch incidence cohort. Schizophrenia Bulletin 1998; 24: 75–85
   PubMed Web of Science ®Google Scholar
• Zhang M., Wang M., Li J., Phillips M. R. Randomised-control trial of family intervention for 78 first-episode male schizophrenic patients: An 18-month study in Suzhou, Jiangsu. British Journal of Psychiatry 1994; 165(Suppl. 24)96–102
   Google Scholar
• Zimmerman M., Posternak M. A., Chelminski L. Derivation of a definition of remission on the Montgomery-Asberg Depression Rating Scale corresponding to the definition of remission on the Hamilton Rating Scale for Depression. Journal of Psychiatric Research 2004; 38: 577–582
   PubMed Web of Science ®Google Scholar